Avoro Capital Advisors LLC bought a new position in shares of Mind Medicine (MindMed) Inc. (NASDAQ:MNMD – Free Report) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund bought 5,000,000 shares of the company’s stock, valued at approximately $66,950,000. Mind Medicine (MindMed) accounts for 0.6% of Avoro Capital Advisors LLC’s portfolio, making the stock its 24th largest holding.
Other institutional investors and hedge funds also recently modified their holdings of the company. ExodusPoint Capital Management LP bought a new position in Mind Medicine (MindMed) during the fourth quarter worth about $254,000. Marex Group plc acquired a new position in Mind Medicine (MindMed) in the 4th quarter worth $268,000. EntryPoint Capital LLC acquired a new position in Mind Medicine (MindMed) in the 4th quarter worth $271,000. Concurrent Investment Advisors LLC bought a new position in Mind Medicine (MindMed) during the 4th quarter worth about $273,000. Finally, PSP Research LLC bought a new stake in shares of Mind Medicine (MindMed) in the fourth quarter worth $467,000.
Mind Medicine (MindMed) Stock Performance
MNMD stock opened at $0.69 on Friday. The business has a fifty day moving average of $0.69.
Mind Medicine (MindMed) (NASDAQ: MNMD) is a clinical-stage biotechnology company focused on developing psychedelic-inspired medicines and accompanying therapeutic protocols to treat mental health disorders and substance use disorders. The company’s research emphasizes both novel small molecules and established psychedelic compounds used in controlled, clinically supervised settings, with the goal of creating safe, scalable treatments that combine pharmacology with psychotherapy.
MindMed’s activities include preclinical research, clinical trials, and the development of treatment delivery models and protocols that integrate drug administration with therapeutic support.
Featured Articles
- Five stocks we like better than Mind Medicine (MindMed)
- Aehr Spikes on New Order, But Has Stock Gotten Ahead of Itself?
- Rackspace’s AI Land Grab: Plugging Into the Next Compute Boom
- Satellogic Is Tiny But Its Revenue Growth Is Hard to Ignore
- Why Kroger’s Pullback Could Be a Gift for Patient Investors
Want to see what other hedge funds are holding MNMD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Mind Medicine (MindMed) Inc. (NASDAQ:MNMD – Free Report).
Receive News & Ratings for Mind Medicine (MindMed) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mind Medicine (MindMed) and related companies with MarketBeat.com's FREE daily email newsletter.
